Institution
Liver Institute Northwest
- 9running trials
- 10closed trials
- 273publications (OpenAlex)
Running trials
Recruiting
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)
Active, not recruiting
Active, not recruiting
Active, not recruiting
Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Primary biliary cholangitis1 recruiting
Closed trials
Completed
Completed
Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed NASH
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Efocipegtrutide (HM15211) in Adults With Biopsy-Confirmed Nonalcoholic Steatohepatitis (NASH)
Completed
Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)
Registry name variants (2)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Liver Institute Northwest
Seattle, Washington 98105
18 trials
Liver Institute Northwest, PLLC
Seattle, Washington 98195
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Primary biliary cholangitis30 works · 5 trials
Institution data: ROR 02jrddb23 (CC0-1.0)Updated 15 Nov 2026